Mylan (Switzerland) - Academic Profile

Publications

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff , Thomas J. Ervin , Francis P. Arena +20 more

In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but...

2013 New England Journal of Medicine 6383 citations

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Haydar Frangoul , David Altshuler , Maria Domenica Cappellini +23 more

Transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) are severe monogenic diseases with severe and potentially life-threatening manifestations. BCL11A is a tr...

2020 New England Journal of Medicine 1646 citations

Affiliated Researchers

Maria Domenica Cappellini

Mylan (Switzerland)

Institution Info

Type: company
Country: CH
Publications: 2
Citations: 8,029

External Links

Identifiers

ROR: https://ror.org/045sjkt56